Sharda University and Nanoved Research Foundation have developed HARAS, a nanotechnology-based nutraceutical using curcumin to reduce carbon monoxide levels in smokers’ lungs. Clinical trials demonstrated significant reductions in CO levels, affirming HARAS’s efficacy in protecting smokers’ lung health. This breakthrough offers a promising solution to combat smoking-related diseases, with HARAS available in both liquid and capsule forms for convenient access and integration into treatment plans.
Home » Combatting Smoking Risks: HARAS Nanotech Nutraceutical Offers Hope for Lung Health
Combatting Smoking Risks: HARAS Nanotech Nutraceutical Offers Hope for Lung Health
Facebook
Twitter
LinkedIn
Email
WhatsApp
Facebook
Twitter
LinkedIn
Email
WhatsApp
Related Shorts
Dietary Zinc Could Lower Endometriosis Risk
November 2, 2024
Grape Seed Extract for Mood Regulation and Cognitive Health
October 24, 2024
Menthol : A Novel Therapeutic Pathway for Alzheimer’s
October 24, 2024
Vitamin D and Probiotics: A New Strategy for Managing Migraines
October 18, 2024
Spermidine: The Polyamine with Potential for a Healthier Heart!
October 18, 2024